Nanotechnology, or "science of extremely small," has immense potential in healthcare, including

more effective drug delivery, faster and more sensitive illness diagnosis, vaccine delivery via
aerosols and patches, and improved visual imaging. Nanotechnology is at the forefront of rapid
healthcare product development because it has a wide range of potential human health
benefits, but it is also viewed with some skepticism because of its potential human health
dangers.

Scientists can use nanotechnology to ensure that medicines are given to specific areas of the
body with greater precision, and the drugs can be made so that the active ingredient enters cell
membranes more effectively, minimizing the required dose. Nanoparticle-based site-specific
targeted medication delivery is more effective for enhanced bioavailability, low side effects, less
toxicity to other organs, and is less expensive. Nanobiomagnets are magnetic nanoparticles that
deliver medications into the body, such as cancer medicines, and are held at the target place by
an external magnet. The goal is to keep the medicine concentrated at the tumor site long
enough for it to be absorbed.

Nanoparticles can improve the resolution of medical imaging tools, making it easier to detect
disease in disease detection and monitoring. Nanotubes and nanoparticles can also be utilized
as glucose, carbon dioxide, and cholesterol sensors, as well as for in-situ monitoring of
homeostasis, the process by which the body maintains metabolic equilibrium, in health
monitoring.

Furthermore, India's Central Scientific Instruments Organisation has developed a

nanotechnology-based tuberculosis testing kit that is currently being tested in clinical trials. This
would reduce the cost and time required for TB tests, as well as the amount of blood required
for testing. Nanotechnology is also being used to better treat tuberculosis.
Nanotechnology-based drug formulations degrade more slowly, allowing more of the active
component to be administered with fewer doses.